DNA RNA and Cells
23 January 2023
Neurogene Announces FDA Clearance of IND for NGN-401 Gene Therapy for Children with Rett Syndrome21 January 2023
ADARx Pharmaceuticals Announces Dosing of First Cohort in Phase 1 Clinical Study of ADX-32420 January 2023
Stemedica Initiating Phase IIb/III Clinical Trial for Patients with Chronic Ischemic Stroke16 January 2023
EverImmune launches phase I clinical trial for its oncobiotic drug candidate in lung and kidney cancer11 January 2023
Genethon Launches Pivotal Clinical Trial of Gene Therapy for Crigler-Najjar Syndrome, a Rare Liver Disease10 January 2023
Avenge Bio Announces Dosing of First Patient in Phase 1/2 Clinical Trial Evaluating AVB-001 for the Treatment of Ovarian Cancer9 January 2023
Boan Biotech’s First Investigational ADC, BA1301 for Injection, Approved for Clinical Trials in China7 January 2023
Cellenkos Announces First Patient Dosed with CK0804 Cell Therapy in LIMBER-TREG108 Clinical TrialNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports